Impact of integrinβmatrix interaction an
β
Thomas J. Kaido; Mayra Yebra; Hideaki Kaneto; Vincenzo Cirulli; Alberto Hayek; A
π
Article
π
2010
π
John Wiley and Sons
π
English
β 430 KB
## Abstract A critical shortage of donor pancreata currently prevents the development of a universal cellβbased therapy for type I diabetes. The ex vivo expansion of insulinβproducing Ξ²βcells offers a potential solution but is problematic due to the inherent tendency of these cells to transition in